PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 11 PubMed articles · model: gemma4:31b
Summary
Background
Active compounds
Mechanism of action
Clinical evidence
Zephygranditines 1-3 exhibited cytotoxic activity in vitro with IC50 values <20 μM [PMID:30179638]
Zephyranthines 2 and 3 exhibited significant in vitro cytotoxic activities against six glioma cell lines with IC50 values <20 μM [PMID:33502261]; additionally, lycorine and haemanthamine showed prominent cytotoxic activity against rat glioma cells (C-6) [PMID:23513717]
Zephygranditines 1 and 2 displayed anti-inflammatory activity by inhibiting nitric oxide production and Cox-1/Cox-2 in vitro [PMID:30179638]
Evidence summary
PubMed sources
- 1.PMID: 30179638 (2018) — Cytotoxic and anti-inflammatory active plicamine alkaloids from Zephyranthes grandiflora. · Fitoterapia
- 2.PMID: 39065458 (2024) — Tissue-Specific Natural Synthesis of Galanthaminein Zephyranthes Species and Its Accumulation in Different In Vitro-Grown Organs Following Methyl Jasmonate Treatment. · Plants (Basel, Switzerland)
- 3.PMID: 33502261 (2022) — Cytotoxic plicamine alkaloids from the whole plants of Zephyranthes grandiflora. · Journal of Asian natural products research
- 4.PMID: 33442831 (2021) — Mass propagation through direct and indirect organogenesis in three species of genus Zephyranthes and ploidy assessment of regenerants through flow cytometry. · Molecular biology reports
- 5.PMID: 22939505